Parkinson’s Awareness Month: Why Early Diagnosis and Timely Treatment Matter
Dr Sarat Chandra
As the world observes Parkinson’s Awareness Month, there is need for renewed focus on building awareness, promoting early diagnosis, and strengthening access to treatment for it. Parkinson’s disease a progressive neurological condition that affects over 10 million people globally. It is among the fastest-growing neurological disorders worldwide. Despite its increasing prevalence, it is widely misunderstood, often under-recognised, and inadequately treated.
Understanding Parkinson’s Disease and Treatment Advances
Parkinson’s disease is a progressive neurodegenerative condition characterised by the gradual loss of dopamine-producing cells in brain. This leads to both motor and non-motor symptoms that can significantly impact quality of life. Many patients can be managed effectively with medications in the early stages. But, a considerable number experience fluctuations in symptom control over time. They have ‘on-off’ periods and a reduced response to therapy.
In such situations, advanced treatments like Deep Brain Stimulation (DBS) can offer meaningful benefits. It modulates abnormal brain circuits and provides more consistent symptom control. Over the years, DBS has evolved with innovations such as adaptive stimulation, directional leads, and AI-enabled programming. This has enabled more precise and personalised treatment. From a clinical standpoint, adopting a multidisciplinary approach and evaluating patients at the appropriate stage is critical. Timely intervention can play a key role in improving long-term outcomes. And, it also helps patients maintain independence and functional ability.
Parkinson’s disease is a long-term, degenerative disorder of the central nervous system. It is marked by the gradual loss of dopamine-producing neurons in the brain. This leads to challenges in movement and coordination. While the exact cause is not fully understood, it is believed to result from a combination of genetic predisposition and environmental influences. Although it is more commonly seen in individuals above 60 years of age, nearly 10–15% of cases occur in those under 50, highlighting the importance of awareness across age groups.
Recognising Early Signs and Symptoms
A major challenge in managing Parkinson’s disease is delayed diagnosis. Early symptoms are often subtle and can be mistaken for normal ageing, resulting in delays in seeking medical care.
Key motor symptoms include tremors at rest, slowness of movement, muscle stiffness, postural instability, and freezing of gait all of which can progressively affect an individual’s mobility and independence.
Beyond motor symptoms, Parkinson’s disease is also associated with a range of non-motor symptoms that are frequently overlooked but have a significant impact on quality of life. These include depression, anxiety, sleep disturbances, cognitive changes, loss of smell, constipation, and autonomic dysfunction.
Importantly, many of these non-motor symptoms may present years before the onset of motor signs, offering a valuable window for earlier diagnosis and timely intervention.
The Need for Greater Awareness and Timely Care
During Parkinson’s Awareness Month, experts and patient advocates continue to emphasise the need for collective action to improve awareness, reduce stigma, and ensure timely access to appropriate diagnosis and treatment for individuals living with Parkinson’s disease. With ageing populations globally, the overall burden of the disease is expected to rise, underscoring the need for greater investment in research, caregiver support, and healthcare systems.
Patients, families, and caregivers are encouraged to consult a neurologist, neurosurgeon or visit a movement disorders clinic if symptoms are suspected. Early diagnosis and timely management can play a crucial role in improving long-term outcomes and enhancing quality of life.
Dr Sarat Chandra is Professor and Head of the Department – Neurosurgery, AIIMS
